SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-13-005403
Filing Date
2013-11-07
Accepted
2013-11-07 16:07:41
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-Q a50744311.htm 10-Q 842444
2 LOGO logo.jpg GRAPHIC 1811
3 EXHIBIT 31.1 a50744311ex311.htm EX-31.1 15946
4 EXHIBIT 31.2 a50744311ex312.htm EX-31.2 16154
5 EXHIBIT 32.1 a50744311ex321.htm EX-32.1 8017
6 EXHIBIT 32.2 a50744311ex322.htm EX-32.2 8057
  Complete submission text file 0001157523-13-005403.txt   4469509

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT opxa-20130930.xml EX-101.INS 426945
8 XBRL TAXONOMY EXTENSION SCHEMA opxa-20130930.xsd EX-101.SCH 48811
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opxa-20130930_cal.xml EX-101.CAL 40459
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opxa-20130930_def.xml EX-101.DEF 277903
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE opxa-20130930_lab.xml EX-101.LAB 372800
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opxa-20130930_pre.xml EX-101.PRE 321713
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 131200673
SIC: 2834 Pharmaceutical Preparations